Inflammation: the link between insulin resistance, obesity and diabetes.
By P. Dandona, A. Aljada, A. Bandyopadhyay. Trends in immunology, 2004
2,232 citations recorded by the source corpus.
Subfields: Endocrine and Autonomic Systems, Epidemiology, Physiology
View Paper: https://www.semanticscholar.org/paper/9c753caf4e96f16629b3f0154021e6b12c39d999
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrine and Autonomic Systems
In Epidemiology
- A. M. Petersen
- B. K. Pedersen
- C. Fischer
- R. Lopez
- N. Zein
- Mitchell A. Lazar
- M. Qatanani
- G. Hotamışlıgil
In Physiology
- B. K. Pedersen
- A. M. Petersen
- C. Fischer
- M. Qatanani
- A. Nielsen
- J. Zierath
- Mitchell A. Lazar
- G. Hotamışlıgil
Citations in the corpus
- Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis (2008, background): “Since obesity, diabetes, and even impaired glucose tolerance are associated with increased levels of circulating IL-6”
- Mechanisms of obesity-associated insulin resistance: many choices on the menu. (2007, background): “Thus, a better understanding of the molecular mechanisms underlying insulin resistance will be required to combat the epidemics of T2DM and cardiovascular disease that are fueled by obesity-associated insulin resistance.”
- Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics (2007, neutral): “signaling [145, 146].”
- Brain-derived neurotrophic factor (BDNF) and type 2 diabetes (2007, background): “Inflammation has been suggested as a key factor in insulin resistance [30].”
- Inflammation and metabolic disorders (2006, background): “Unequivocal experimental, epidemiological and clinical evidence produced during the past decade causally links inflammation, or the molecules and networks integral to inflammatory responses, to the development of these metabolic diseases and/or the complications that emerge from these pathologies, p”
- Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. (2005, background): “Low-grade systemic inflammation is a feature of obesity and insulin resistance (1).”